Deafness-lymphedema-leukemia syndrome: genes and variants

Explore variant evidence for Deafness-lymphedema-leukemia syndrome across 1 analyzed protein (GATA2). Linked ClinVar records include 35 pathogenic or likely pathogenic variants, 549 variants of uncertain significance and 47 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Deafness-lymphedema-leukemia syndrome

Where Deafness-lymphedema-leukemia syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Deafness-lymphedema-leukemia syndrome

VariantPositionProtein partClinical label
GATA2 T354M354GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 R398Q398Pathogenic / likely pathogenic (★★)
GATA2 R398W398Pathogenic / likely pathogenic (★★)
GATA2 C349R349GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 C349Y349GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 C352G352GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 C352R352GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 R361G361GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 C373R373GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 L375F375Pathogenic / likely pathogenic (★★)
GATA2 R396W396Pathogenic / likely pathogenic (★★)
GATA2 R396L396Pathogenic / likely pathogenic (★★)
GATA2 R396Q396Pathogenic / likely pathogenic (★★)
GATA2 A372T372GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 R362P362GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 N371K371GATA-type 2Pathogenic / likely pathogenic (★★)
GATA2 Y377D377Pathogenic / likely pathogenic (★★)
GATA2 T354R354GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 C349F349GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 C349G349GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 C352F352GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 T354P354GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 R361L361GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 C373Y373GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 L375V375Pathogenic / likely pathogenic (★)
GATA2 R398G398Pathogenic / likely pathogenic (★)
GATA2 T358N358GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 W360L360GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 C370W370GATA-type 2Pathogenic / likely pathogenic (★)
GATA2 P385Q385Pathogenic / likely pathogenic (★)
GATA2 L315P315GATA-type 1Pathogenic / likely pathogenic (★)
GATA2 A318T318GATA-type 1Pathogenic / likely pathogenic (★)
GATA2 R384G384Pathogenic / likely pathogenic (★)
GATA2 M388T388Pathogenic / likely pathogenic (★)
GATA2 S447R447Pathogenic / likely pathogenic (★)

Uncertain variants prioritized for review in Deafness-lymphedema-leukemia syndrome

VariantPositionProtein partClinical labelEvidence
GATA2 M388V388Conflicting reports (★)+7: 2 other pathogenic changes within 3 positions; M388T at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.966
GATA2 W360R360GATA-type 2Conflicting reports (★)+6: 5 other pathogenic changes within 3 positions; W360L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GATA2 R361H361GATA-type 2Conflicting reports (★)+6: 5 other pathogenic changes within 3 positions; R361G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GATA2 R362Q362GATA-type 2Conflicting reports (★)+6: 4 other pathogenic changes within 3 positions; R362P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GATA2 C370Y370GATA-type 2Uncertain (★)+6: 5 other pathogenic changes within 3 positions; C370W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GATA2 P385L385Uncertain (★★)+6: 3 other pathogenic changes within 3 positions; P385Q at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
GATA2 A318V318GATA-type 1Uncertain (★)+6: 2 other pathogenic changes within 3 positions; A318T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00

Which prediction tools work for Deafness-lymphedema-leukemia syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Deafness-lymphedema-leukemia syndrome

Frequently asked questions

Which genes have records linked to Deafness-lymphedema-leukemia syndrome?

This view contains 1 analyzed proteins: GATA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 35 pathogenic or likely pathogenic variants, 549 variants of uncertain significance and 47 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 7 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 652 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center